Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS)

MS Treatments

Jahr

Publikationsjahr
2016

Autoren

Autorenliste der Publikation
Ziemssen T, Engelmann U, Jahn S, Leptich A, Kern R, Hassoun L, Thomas K.

Verlag

Publisher-Information
BMC Neurol. 2016 Jul 19;16:109.

Link

Zur Publikation (externer Server)
https://doi.org/10.1186/s12883-016-0629-9

Tags

Forschungsthemen
Multiple SkleroseMS Behandlung
Treatments2016